What Idaho's 1115 Behavioral Health Waiver Means for Facilities

Idaho's Section 1115 Behavioral Health Transformation waiver lets Idaho Medicaid pay for residential treatment and withdrawal management stays for adults 21 to 64 in IMD facilities, authorized through March 31, 2027. Billing requires national accreditation, an ASAM Level of Care certification for residential providers that contract with the department, and Magellan of Idaho (IBHP) network enrollment. The waiver also sets a 30-day statewide average length of stay with 60-day and 45-day limits on the stays for which the state may claim federal funding.

That authority, approved by CMS on April 17, 2020 and available as CMS approved the implementation plans, turns a population that the federal IMD exclusion would otherwise leave to self-pay, grants, or short crisis-only coverage into a Medicaid-billable payer segment. For anyone modeling a new Idaho facility or evaluating an existing one, it is the single biggest variable on the revenue side of the pro forma.

What Is Idaho's 1115 Behavioral Health Transformation Waiver?

Idaho's Behavioral Health Transformation demonstration is a Section 1115 Medicaid waiver, first approved by the Centers for Medicare & Medicaid Services (CMS) on April 17, 2020. Section 1115 lets a state ask CMS for permission to pay federal Medicaid dollars for services or settings the underlying Medicaid statute would otherwise exclude. In Idaho's case, the exclusion at issue is the IMD exclusion: the decades-old federal rule that blocks federal Medicaid payment for adults aged 21 to 64 in an institution for mental diseases, which 42 CFR 435.1010 defines as an institution of more than 16 beds primarily engaged in diagnosing, treating or caring for people with mental diseases, including substance use disorders. The 2020 approval letter covers "inpatient, residential and other services" for adults 21 to 64 residing in IMDs with a substance use disorder (SUD), serious mental illness (SMI) or serious emotional disturbance, once CMS approved the state's implementation plans. For the full picture of how this waiver fits alongside Idaho's licensing and accreditation framework, see our Idaho behavioral health licensing guide.

What Does the Waiver Cover for Residential and Withdrawal Management Facilities?

The April 17, 2020 approval extends federal financial participation (FFP) to adults 21 to 64 in IMD-classified residential and inpatient settings, including those "primarily receiving SUD treatment and withdrawal management services," once CMS approved Idaho's SUD implementation plan. A later amendment, approved March 29, 2024, authorized payments to legally responsible individuals for personal care services, and an amendment approved May 15, 2025 ended that authority. Neither changed this coverage. That is the provision operators actually feel: it is what makes a residential SUD program or a freestanding withdrawal management unit fundable through Idaho Medicaid rather than self-pay or grant funding alone. For the licensure and accreditation mechanics behind each setting, see our guides to residential treatment center licensing in Idaho and Idaho withdrawal management and detox licensing.

The waiver's special terms and conditions add a length-of-stay mechanism (STCs 17 and 22) that operators building a pro forma need to understand. STC 17 expects a statewide average length of stay of 30 days, and STC 22 limits the stays for which the state may claim federal funding to 60 days if the state meets that average at the midpoint assessment, or 45 days if it does not. STC 22 appears under the SMI/SED provisions, so confirm with the state how it applies to SUD residential and withdrawal management stays:

• 30-day target. Idaho must maintain a statewide average length of stay (ALOS) of 30 days across residential and inpatient IMD settings.
• 60 days if the state meets the target. When Idaho shows at the midpoint assessment that it meets the 30-day statewide ALOS, the state may claim federal funding for stays of up to 60 days.
• 45 days if it does not. If the state cannot show that it meets the benchmark within one standard deviation at the midpoint assessment, the state may claim federal funding only for stays of up to 45 days until it can.

That statewide, aggregate metric is outside any single facility's control, but it is directly influenced by how every IBHP-network facility manages length of stay and discharge planning. A program that habitually pushes stays past what clinical necessity supports doesn't just risk its own utilization review findings. It drags on the number every facility in the state is measured against.

Is the Waiver Still in Effect in 2026?

Yes. As of this writing, CMS's demonstration record for Idaho shows the program authorized through March 31, 2027, with Idaho's formal extension application (filed March 12, 2025) still under review and CMS granting temporary extensions to bridge the gap, most recently on August 28, 2026. In practice, that means the revenue authority described in this post is active today, but it is not permanent law: it is a demonstration that Idaho has to keep re-justifying to CMS on a defined evaluation cycle, including annual monitoring reports and an interim evaluation. Operators underwriting a facility on this payer stream should build refinancing and extension risk into their assumptions the same way they would with any grant-funded or demonstration-dependent revenue line, and should revisit the current expiration date on the Medicaid.gov demonstration page for Idaho before finalizing a five-year model.

How Does This Change a Facility's Payer Mix and Revenue Model?

Without the waiver, an Idaho residential SUD or withdrawal management program serving adults 21 to 64 in an IMD-classified facility would have essentially three revenue options: private pay, philanthropic or state grant funding, or narrow crisis-stabilization carve-outs that don't cover a full residential episode. The federal IMD exclusion keeps Idaho Medicaid out of that list. The waiver adds Idaho Medicaid, routed today through the Magellan of Idaho (IBHP) network, as a fourth, standing revenue source, without removing the other three.

For a founder building a first Idaho facility, that changes the census assumptions that drive the whole pro forma: a payer mix that used to be self-pay-heavy, with a hard ceiling on how many beds could realistically fill given local ability to pay, can now model a Medicaid-eligible segment of the 21 to 64 adult population as a genuine demand source. For an existing operator, it changes the calculus on whether beds that have been sitting idle waiting for private-pay or grant-funded clients should be reactivated for Medicaid-eligible adults, and whether it's worth adding IMD-eligible capacity at all. Our behavioral health startup consulting builds that pro forma and payer strategy for first Idaho facilities.

It doesn't change everything. The 30/45/60-day length-of-stay mechanics mean this isn't a payer that rewards long-stay, low-acuity residential models. It rewards programs built around a clearly staged, clinically justified length of stay with a real discharge plan into a lower level of care. Facilities that already run PHP/IOP step-down capacity, or that have a warm referral relationship with one, are better positioned to use this funding than a residential-only operator with no step-down pathway.

Rule status. Idaho moved its substance use disorder service rules from IDAPA 16.07.17 into Title 39, Chapter 3 of Idaho Code through Senate Bill 1024, effective July 1, 2025. The bill's Statement of Purpose says it does not increase or reduce service levels. The residential accreditation requirement now names CARF only, where the former rule also accepted the Joint Commission and the Council on Accreditation. References to IDAPA 16.07.17 in this article point to the final published version of the rule.

What Do You Need in Place to Actually Bill This Revenue?

The waiver creates the funding authority; it doesn't hand it to a facility automatically. The waiver terms and Idaho law tie eligibility to a specific set of operational prerequisites:

• National accreditation. The waiver terms require residential providers to be accredited by a nationally recognized accreditation body before the state can claim federal match for their stays. Since July 1, 2025, Idaho Code 39-306B goes further for residential providers that contract with the Department of Health and Welfare: they must be accredited by CARF. The retired IDAPA 16.07.17.395 had also accepted the Joint Commission and the Council on Accreditation (COA), so confirm with Magellan which accreditations it accepts before choosing one. Our Joint Commission accreditation consulting prepares residential programs for that survey.
• ASAM Level of Care certification. Idaho Code 39-306B also requires an ASAM level of care certification verifying the program can deliver level 3 residential care. Accreditation alone isn't sufficient.
• Magellan of Idaho (IBHP) network enrollment. Idaho Medicaid behavioral health claims for this population route through Magellan of Idaho, which took over the IBHP contract from Optum on July 1, 2024. Credentialing and contracting with Magellan is a separate, sequential step from accreditation, not something that happens automatically once a facility is accredited. Our Magellan of Idaho enrollment guide walks through that process end to end.
• Utilization review and length-of-stay documentation. Because the state is tracking a statewide 30-day ALOS benchmark, expect utilization review of length of stay under Magellan's medical necessity criteria, and build documentation habits now rather than after the first denial.
• Co-morbid health screening. The demonstration's SMI/SED milestones call for participating psychiatric hospitals and residential treatment settings to screen enrollees for co-morbid physical health conditions and substance use disorders and to demonstrate the capacity to address co-morbid physical health conditions during short-term stays.

Every prerequisite on that list is also a service line: accreditation survey readiness sits with our licensing and accreditation consulting, and Magellan credentialing and rate negotiation sit with our payer contracting team. Most Idaho launches need both running at the same time, not sequentially.

How Should You Model This in a Facility Pro Forma?

Because Idaho Medicaid rates and unit-level reimbursement figures for this benefit are negotiated through the Magellan of Idaho contract rather than published in the federal waiver documents, don't build a pro forma on an assumed per-diem rate pulled from a national average. Build it on the structure the waiver actually imposes:

1. Model census by payer segment, not blended average. Separate self-pay/grant-funded census from the Medicaid-eligible 21 to 64 IMD segment. They have different acquisition costs, different average lengths of stay, and different downstream step-down needs.
2. Model length of stay from clinical need and from reported Idaho averages. The state's April 30, 2024 midpoint assessment reported average IMD stays of 4.6 to 7.0 days for SUD and 7.3 to 8.7 days for SMI, far below the 30-day statewide target.
3. Price in the accreditation and IBHP enrollment timeline as a delay to revenue start, not a rounding error. Accreditation surveys, ASAM certification, and Magellan credentialing each run on their own timelines and rarely compress into a single quarter.
4. Build a step-down pathway into the model, even if you don't operate one directly. A documented referral relationship into PHP/IOP materially improves discharge planning and utilization review outcomes for a residential or withdrawal management program billing under this authority.
5. Track the extension risk as a line item, not a footnote. A demonstration authorized through March 2027, with extensions granted incrementally, is a different underwriting proposition than a permanent state-plan benefit.

Readiness Checklist: Billing Idaho's 1115 Waiver Revenue Stream

• Accreditation and ASAM certification secured or scheduled before the launch timeline assumes Medicaid revenue on day one.
• Magellan of Idaho credentialing initiated in parallel with accreditation, not after it's complete.
• Discharge and step-down pathway documented, ideally with a named referral partner for the next level of care.
• UR and length-of-stay documentation workflow built, with clinical staff ownership of medical-necessity documentation for stays approaching the statewide 30-day average.
• Extension risk noted in the financial model, with the current demonstration expiration date cited and revisited annually.

Frequently Asked Questions

What is Idaho's 1115 Behavioral Health Transformation waiver?

It's a Section 1115 Medicaid demonstration, approved by CMS on April 17, 2020, that lets Idaho Medicaid pay federal matching funds for behavioral health services in IMD-classified facilities that would otherwise be excluded from Medicaid coverage under federal law.

Does Idaho Medicaid pay for residential treatment or detox now?

For adults ages 21 to 64 in a nationally accredited, IMD-classified facility enrolled in the Magellan of Idaho (IBHP) network, yes. The waiver authorizes federal funding for residential and inpatient SUD treatment, withdrawal management and serious mental illness stays in IMDs, and that funding became available as CMS approved the state's implementation plans, subject to the waiver's length-of-stay terms.

How long can a facility bill Medicaid for a single IMD stay in Idaho?

The state may claim federal funding for stays of up to 60 days if Idaho meets its statewide 30-day average-length-of-stay benchmark at the midpoint assessment, or up to 45 days if it does not. The benchmark is measured statewide, not per facility, but individual facilities' length-of-stay practices affect it.

Is the waiver still active in 2026?

Yes. As of September 2026, the demonstration is authorized through March 31, 2027, with Idaho's extension application still under CMS review and temporary extensions (most recently approved August 28, 2026) keeping the program running in the meantime.

What accreditation do I need to bill under this waiver?

The waiver's terms require residential providers to be accredited by a nationally recognized accreditation body before Idaho can claim federal match. Separately, since July 1, 2025, Idaho Code 39-306B requires any residential provider contracting with the Department of Health and Welfare to hold CARF accreditation and an ASAM level of care certification for level 3 care.

Do I bill Idaho Medicaid directly, or through Magellan?

Through Magellan of Idaho. Magellan holds the IBHP contract (it replaced Optum on July 1, 2024) and administers behavioral health claims and network credentialing for this population.

How Saint Health Group Helps You Capture This Revenue Stream

Reading the waiver correctly is the easy part. Turning it into billable revenue means sequencing accreditation, ASAM certification, and Magellan of Idaho credentialing so they land in the right order instead of stalling each other, and building the utilization-review and documentation infrastructure a length-of-stay-capped Medicaid benefit demands before your first survey or your first audit, not after. Saint Health Group doesn't just tell you what the waiver allows; as your single accountable partner, we write the policies and procedures, implement them on-site, train your clinical and UR staff, build the documentation infrastructure a length-of-stay-monitored Medicaid benefit requires, run a full readiness survey before the real one, and handle the payer contracting and credentialing conversations with Magellan directly. Whether the gap in your plan is licensing and accreditation, revenue cycle and payer contracting, or the operational infrastructure to support all three at once, we run it end to end. Talk to Saint Health Group about launching or expanding an Idaho facility, or contact our team to start with a readiness assessment.